Boston Sci Makes Its Play In Transcatheter Valves With Sadra Acquisition

Boston Scientific is entering the transcatheter aortic heart valve race in earnest with its deal, announced Nov. 19, to purchase the remainder of start-up firm Sadra Medical for up to $450 million.